For breast cancer, 11 studies reported the association of socio-economic status with the human epidermal growth factor receptor 2 (HER2) targeting monoclonal antibody trastuzumab [29–39] and one with immunotherapy [40]. The gene discussed is ERBB2; the disease is breast cancer.